Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human Subjects
Clinical trial NCT02174523 · COMPLETED
Trial details
- NCT number
- NCT02174523
- Sponsor
- Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2014-04-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.